Randall S. Davis

Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells

Götz R. A. Ehrhardt, Joyce T. Hsu, Lanier Gartland et al. · The Journal of Experimental Medicine · 2005 · 335 citations · Full text

Distinctive Tissue-based Population, Immunology, Humoral Response +18

Identification of a family of Fc receptor homologs with preferential B cell expression

Randall S. Davis, Yui‐Hsi Wang, Hiromi Kubagawa et al. · Proceedings of the National Academy of Sciences · 2001 · 215 citations · Full text

Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement

Douglas B. Johnson, Mellissa J. Nixon, Yu Wang et al. · JCI Insight · 2018 · 155 citations · Full text

Immunology, Immunoediting, Immunologic Mechanism +17

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

William G. Wierda, John C. Byrd, Jeremy S. Abramson et al. · PubMed · 2020 · 143 citations

Hematological Malignancy, Lymphoid Neoplasia, Version 4.2020 +13

The inhibitory potential of Fc receptor homolog 4 on memory B cells

Götz R. A. Ehrhardt, Randall S. Davis, Joyce T. Hsu et al. · Proceedings of the National Academy of Sciences · 2003 · 124 citations · Full text